newsfilter
← Latest News
GlobeNewswire·

Otonomy Reports Second Quarter 2021 Financial Results and Provides Corporate Update

OTO-313 Phase 2 trial in tinnitus ongoing with results expected in mid-2022 OTO-413 Phase 1/2 trial expansion in hearing loss ongoing with results expected in mid-2022 OTO-825 preclinical proof-of-concept results presented at ASGCT meeting; Pre-IND me